OGN
Organon & Co
Price:  
5.84 
USD
Volume:  
2,928,293.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

OGN Relative Valuation

233.2%
Upside

As of 2026-03-28, the Relative Valuation of Organon & Co (OGN) is 19.46 USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.84 USD, the upside of Organon & Co based on Relative Valuation is 233.2%.

The range of the Relative Valuation is 12.71 - 27.64 USD.

Range Selected
Trailing P/E multiples 17.7x - 20.2x 18.8x
Forward P/E multiples 16.5x - 19.8x 18.2x
Fair Price 12.71 - 27.64 19.46
Upside 117.7% - 373.2% 233.2%
5.84 USD
Stock Price
19.46 USD
Fair Price

OGN Relative Valuation - Historical P/E Data

Date P/E
2026-03-27 8.13
2026-03-26 8.42
2026-03-25 8.49
2026-03-24 8.51
2026-03-23 8.48
2026-03-20 8.39
2026-03-19 8.73
2026-03-18 8.67
2026-03-17 8.90
2026-03-16 8.83
2026-03-13 8.84
2026-03-12 8.81
2026-03-11 8.91
2026-03-10 9.02
2026-03-09 9.09
2026-03-06 9.13
2026-03-05 9.34
2026-03-04 9.56
2026-03-03 9.61
2026-03-02 10.01
2026-02-27 10.15
2026-02-26 10.06
2026-02-25 10.45
2026-02-24 11.33
2026-02-23 11.03
2026-02-20 11.28
2026-02-19 10.47
2026-02-18 10.38
2026-02-17 10.13
2026-02-13 10.29
2026-02-12 9.83
2026-02-11 10.71
2026-02-10 10.87
2026-02-09 11.01
2026-02-06 11.43
2026-02-05 11.28
2026-02-04 11.54
2026-02-03 11.14
2026-02-02 11.42
2026-01-30 11.89
2026-01-29 11.97
2026-01-28 12.38
2026-01-27 12.53
2026-01-26 12.67
2026-01-23 13.59
2026-01-22 13.56
2026-01-21 13.35
2026-01-20 13.17
2026-01-16 12.19
2026-01-15 12.11